NCT01936285

Colchicine in ST-elevation Myocardial Infarction

Study of Anti-inflammatory Treatment With Colchicine in the Acute Phase of ST-elevation Myocardial Infarction to Reduce Infarct Size

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: G.Gennimatas General Hospital · Academic / Other
• Sex: All
• Age: 80 Years
• Healthy volunteers: Not accepted

Summary

* There is evidence that inflammatory processes may play detrimental role during the acute phase of myocardial infarction * The hypothesis of this study is that colchicine, by its anti-inflammatory action, may lead to reduction in infarct size, when administered during the acute phase of myocardial infarction

Conditions

• Acute Myocardial Infarction

Interventions

Type	Name	Description
DRUG	Colchicine 2 mg loading dose; 0.5 mg bid for 5 days
DRUG	Placebo

Timeline

• Start date: 2013-07-01
• Primary completion: 2015-04-01
• First posted: 2013-09-06
• Last updated: 2015-04-23

Locations

1 site across 1 country: Greece